Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 1
2020 2
2021 1
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites.
Kityo C, McCarthy C, Koenig SP, Hughes MD, Wallis CL, Tsikhutsu I, Munyanga C, Mwelase N, Van Schalkwyk M, Marc JB, Mponda K, Dawson R, Some FF, Mohapi L, Joseph Y, Parikh UM, Shah NS, Manabe YC, Godfrey C, Woolley E, Mellors JW, Flexner C; ACTG A5381/Hakim Study Team. Kityo C, et al. Among authors: marc jb. Open Forum Infect Dis. 2025 May 2;12(7):ofaf270. doi: 10.1093/ofid/ofaf270. eCollection 2025 Jul. Open Forum Infect Dis. 2025. PMID: 40630936 Free PMC article.
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial.
Severe P, Pierre S, Homeus F, Marc JB, Trevisi L, Aristhomene ML, Bernadin GR, Lavoile K, Rivera V, Duchatellier CF, Joseph MJ, Wu J, Rouzier V, Preval F, Jean E, Bernadin J, Zion A, Pierre Louis Forestal G, Avila-Rios S, Garcia Morales C, Zhang A, Israelski D, Apollon A, Dumont E, Fox E, Cremieux PY, Pape JW, Collins SE, Liautaud B, Sax PE, Koenig SP. Severe P, et al. Among authors: marc jb. Lancet HIV. 2025 Sep;12(9):e616-e626. doi: 10.1016/S2352-3018(25)00130-4. Lancet HIV. 2025. PMID: 40883049 Clinical Trial.
Age discrimination in out-of-hospital cardiac arrest care: a case-control study.
Wiel E, Di Pompéo C, Segal N, Luc G, Marc JB, Vanderstraeten C, El Khoury C, Escutnaire J, Tazarourte K, Gueugniaud PY, Hubert H; GR-RéAC. Wiel E, et al. Among authors: marc jb. Eur J Cardiovasc Nurs. 2018 Aug;17(6):505-512. doi: 10.1177/1474515117746329. Epub 2017 Dec 5. Eur J Cardiovasc Nurs. 2018. PMID: 29206063
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
Metcalfe JZ, Weir IR, Scarsi KK, Mendoza-Ticona A, Pierre S, Hall L, Leon-Cruz J, Svensson EM, Koele SE, Samaneka W, Kanyama C, Yohane M, Nevrekar N, Ntsalaze B, Marc JB, Goth M, Maartens G, Chaisson R; ACTG A5362 study team. Metcalfe JZ, et al. Among authors: marc jb. Lancet Infect Dis. 2025 Sep 4:S1473-3099(25)00436-0. doi: 10.1016/S1473-3099(25)00436-0. Online ahead of print. Lancet Infect Dis. 2025. PMID: 40915311 Free article.
Can We Define Termination Of Resuscitation Criteria In Out-Of-Hospital Hanging?
Escutnaire J, Ducrocq F, Singier A, Baert V, Babykina E, Dumont C, Vilhelm C, Marc JB, Segal N, Wiel E, Mols P, Hubert H; GR-RéAC. Escutnaire J, et al. Among authors: marc jb. Prehosp Emerg Care. 2019 Jan-Feb;23(1):58-65. doi: 10.1080/10903127.2018.1476635. Epub 2018 Aug 17. Prehosp Emerg Care. 2019. PMID: 30118612
Early initiation of fast-track care for persons living with HIV initiating dolutegravir-based regimens during a period of severe civil unrest in Port-au-Prince, Haiti: a pilot randomized trial.
Marc JB, Pierre S, Ducatel O, Homeus F, Zion A, Rivera VR, Dorvil N, Severe P, Guiteau C, Rouzier V, Katz IT, Duchatelier CF, Forestal GPL, Jean J, Bernadin G, Dumont ED, Riche RCB, Pape JW, Koenig SP. Marc JB, et al. J Int AIDS Soc. 2025 Feb;28(2):e26419. doi: 10.1002/jia2.26419. J Int AIDS Soc. 2025. PMID: 39924611 Free PMC article. Clinical Trial.
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study.
Marc JB, McCarthy C, Wallis CL, Kityo C, Hughes MD, Godfrey C, Shah NS, Parikh UM, Maartens G, Kanyike F, Van Schalkwyk M, Kihumuro RB, Asiimwe P, Tsikhutsu I, Munyanga C, Some FF, Joseph Y, Flowers T, Mohapi L, Samaneka WP, Mponda K, Rassool MS, Pierre S, Woolley E, Manabe YC, Mellors JW, Flexner C, Koenig SP, Mngqibisa R; ACTG A5381–Hakim Study Team. Marc JB, et al. Lancet HIV. 2025 Dec;12(12):e836-e849. doi: 10.1016/S2352-3018(25)00162-6. Lancet HIV. 2025. PMID: 41314742